The Journal of Hepatology now has an Impact Factor of 11.336, making it the fastest growing and most consistently impactful hepatology publication globally.
"The Journal is now 1st in the field of Hepatology, thanks in large part to the sustained efforts and momentum of the EASL's Editorial Office and previous Editorial teams, led in the past 10-years by Professor Massimo Colombo and Professor Didier Samuel,” explained the Journal of Hepatology’s current Editor-in-Chief, Professor Rajiv Jalan. “The current Editorial team takes this opportunity to gratefully acknowledge and thank all the authors of the excellent manuscripts, the reviewers and the readers, whose contributions to this success are equally important.”
This is the highest Impact factor that the Journal of Hepatology has achieved and marks EASL's commitment to providing the liver community with the most up-to-date work and data of the highest quality.
“EASL is always looking to the future, and how best to serve its members and various stakeholders. This public recognition further highlights EASL’s commitment to the community as The Home of Hepatology – and just how far along that path we have come" said Laurent Castera, EASL’s Secretary General.
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter